Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:ABBV NASDAQ:CCOI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$256.18+1.1%$230.81$184.90▼$261.64$452.62B0.37.12 million shs4.65 million shsCCOICogent Communications$12.70+2.4%$15.21$10.93▼$50.37$636.02M0.81.24 million shs1.05 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie-0.45%+2.14%+16.96%+23.63%+33.88%CCOICogent Communications+13.04%-4.10%-12.61%-47.23%-75.20%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABBVAbbVie$256.18+1.1%$230.81$184.90▼$261.64$452.62B0.37.12 million shs4.65 million shsCCOICogent Communications$12.70+2.4%$15.21$10.93▼$50.37$636.02M0.81.24 million shs1.05 million shs7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABBVAbbVie-0.45%+2.14%+16.96%+23.63%+33.88%CCOICogent Communications+13.04%-4.10%-12.61%-47.23%-75.20%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABBVAbbVie 2.84Moderate Buy$267.674.48% UpsideCCOICogent Communications 2.18Hold$24.9096.06% UpsideCurrent Analyst Ratings BreakdownLatest ABBV and CCOI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/15/2026ABBVAbbVie CitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$230.00 ➝ $260.007/13/2026ABBVAbbVie UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$230.00 ➝ $260.007/13/2026ABBVAbbVie BMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$258.00 ➝ $300.007/10/2026ABBVAbbVie Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$260.00 ➝ $295.007/10/2026ABBVAbbVie Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$234.00 ➝ $276.007/10/2026ABBVAbbVie Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$260.00 ➝ $280.007/9/2026ABBVAbbVie GuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$249.00 ➝ $261.007/9/2026ABBVAbbVie JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$260.00 ➝ $280.007/6/2026ABBVAbbVie HSBCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$300.007/6/2026ABBVAbbVie Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOverweight$240.00 ➝ $265.006/22/2026CCOICogent Communications TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy(Data available from 7/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABBVAbbVie$62.82B7.21$15.25 per share16.80($1.83) per share-139.99CCOICogent Communications$975.77M0.65$1.78 per share7.13($1.30) per share-9.77Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABBVAbbVie$4.23B$2.03126.2015.820.845.79%-576.45%13.39%7/31/2026 (Estimated)CCOICogent Communications-$182.17M-$3.55N/AN/AN/A-17.53%-842.48%-5.40%8/6/2026 (Estimated)Latest ABBV and CCOI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026CCOICogent Communications-$0.9651N/AN/AN/A$239.75 millionN/A7/31/2026Q2 2026ABBVAbbVie$3.66N/AN/AN/A$16.78 billionN/A5/4/2026Q1 2026CCOICogent Communications-$1.03-$0.83+$0.20-$0.83$241.31 million$239.19 million4/29/2026Q1 2026ABBVAbbVie$2.59$2.65+$0.06$0.39$14.72 billion$15.00 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABBVAbbVie$6.922.70%+6.80%340.89%53 YearsCCOICogent Communications$0.080.63%+1.87%N/A 14 YearsLatest ABBV and CCOI DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/18/2026ABBVAbbViequarterly$1.732.83%7/15/20267/15/20268/14/20265/1/2026CCOICogent Communicationsquarterly$0.020.46%5/18/20265/18/20266/2/2026(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABBVAbbVieN/A0.800.68CCOICogent CommunicationsN/A1.901.90Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABBVAbbVie70.23%CCOICogent Communications92.45%Insider OwnershipCompanyInsider OwnershipABBVAbbVie0.06%CCOICogent Communications4.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABBVAbbVie57,0001.77 billion1.77 billionOptionableCCOICogent Communications1,83350.08 million47.98 millionOptionableABBV and CCOI HeadlinesRecent News About These CompaniesBrokerages Set Cogent Communications Holdings, Inc. (NASDAQ:CCOI) Target Price at $24.90July 21 at 3:47 AM | americanbankingnews.comCogent Communications (NASDAQ:CCOI) Shares Up 5.7% - Should You Buy?July 20 at 1:39 PM | marketbeat.comCogent Communications (NASDAQ:CCOI) Hits New 12-Month Low - What's Next?July 17, 2026 | marketbeat.comCogent Communications Holdings, Inc. (NASDAQ:CCOI) Receives Average Recommendation of "Hold" from AnalystsJuly 16, 2026 | marketbeat.comCogent Communications to Host Second Quarter 2026 Earnings Call on August 6, 2026July 15, 2026 | prnewswire.comCogent Communications (NASDAQ:CCOI) Trading Down 5.4% - Should You Sell?July 14, 2026 | marketbeat.comAnalysts Have Conflicting Sentiments on These Communication Services Companies: Netflix (NFLX) and Cogent Comms (CCOI)July 10, 2026 | theglobeandmail.comCogent Communications (NASDAQ:CCOI) Stock Price Up 6% - Time to Buy?July 8, 2026 | marketbeat.comHow Cogent Communications’ (CCOI) Data Center Sale Sharpens Its Network-Focused Turnaround CaseJuly 7, 2026 | insidermonkey.comCogent Communications (NASDAQ:CCOI) Hits New 52-Week Low - Here's WhyJuly 7, 2026 | marketbeat.comCogent Communications (NASDAQ:CCOI) Trading Down 5.9% - Here's WhyJuly 6, 2026 | marketbeat.com1 Services Stock to Target This Week and 2 We Brush OffJuly 3, 2026 | finance.yahoo.comcogent communications holdings inc. - CCOIJune 30, 2026 | foxbusiness.comWhy Cogent (CCOI) stock is trading up todayJune 30, 2026 | msn.comCogent Communications (NASDAQ:CCOI) Hits New 52-Week Low - Time to Sell?June 30, 2026 | marketbeat.comCogent Communications Announces Closing of Sale of 10 Data Center FacilitiesJune 29, 2026 | prnewswire.comCogent Communications (NASDAQ:CCOI) Trading Down 6.6% - Time to Sell?June 29, 2026 | marketbeat.comCogent Communications (NASDAQ:CCOI) Raised to Sell at Wall Street ZenJune 27, 2026 | marketbeat.comZacks Research Has Pessimistic View of CCOI FY2028 EarningsJune 25, 2026 | marketbeat.comCogent Communications (NASDAQ:CCOI) Reaches New 12-Month Low - Here's WhyJune 24, 2026 | marketbeat.comCogent Communications (NASDAQ:CCOI) Trading 11.3% Higher - Here's What HappenedJune 22, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeABBV and CCOI Company DescriptionsAbbVie NYSE:ABBV$256.18 +2.80 (+1.11%) Closing price 03:59 PM EasternExtended Trading$255.56 -0.62 (-0.24%) As of 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.Cogent Communications NASDAQ:CCOI$12.70 +0.30 (+2.42%) Closing price 04:00 PM EasternExtended Trading$13.08 +0.38 (+2.95%) As of 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Cogent Communications Holdings, Inc., through its subsidiaries, provides high-speed Internet access, private network, and data center colocation space services in North America, Europe, Oceania, South America, and Africa. The company offers on-net Internet access and private network services to law firms, financial services firms, and advertising and marketing firms, as well as heath care providers, educational institutions and other professional services businesses, other Internet service providers, telephone companies, cable television companies, web hosting companies, media service providers, mobile phone operators, content delivery network companies, and commercial content and application service providers. It also provides Internet access and private network services to customers that are not located in buildings directly connected to its network; and on-net services to customers located in buildings that are physically connected to its network. In addition, the company offers off-net services to corporate customers using other carriers' circuits to provide the last mile portion of the link from the customers' premises to the network. Further, it operates data centers that allow its customers to collocate their equipment and access the network. It serves primarily to small and medium-sized businesses, communications service providers, and other bandwidth-intensive organizations. Cogent Communications Holdings, Inc. was founded in 1999 and is headquartered in Washington, the District of Columbia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3M's Redemption Arc: Can Q2 Earnings Change the Narrative? Alphabet Is Planning a New AI Chip. Here's Why It Matters Ahead of Earnings 3 Photonics Companies Making Quantum Tech Possible Confidence Is Back, But Earnings Show the Consumer Is Being Picky Industrial and Utility Giants Boost Dividends as Data Center Tailwinds Build IREN’s $2.8 Billion AI Contract Haul Changes the Stock’s Story AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off 2 ETFs to Access the World's Best-Performing Stock Markets In 2026 Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
